Superworth

Jaguar Health EPS JAGX

Diluted earnings per share by quarter and over the last twelve months, from 2014.

Last 12 months, to Jun 30, 2026
−$6051.75
Latest quarter, Q2 FY26
−$235.50
Fiscal year 2025
−$19763.10

Jaguar Health's earnings per share was −$6051.75 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$235.50.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$19763.10n/a
FY2024−$69515.25n/a
FY2023−$2869781.25n/a
FY2022−$35075250.00n/a
FY2021−$69103125.00n/a
FY2020−$240975000.00n/a
FY2019−$6137775000.00n/a
FY2018−$30495740625.00n/a
FY2017−$112868437500.00n/a
FY2016−$254884218750.00n/a
FY2015−$613954687500.00n/a
FY2014−$602791875000.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$235.50n/a−$6051.75
Q1 FY26−$204.00n/a−$11200.35
Q4 FY25−$2315.25n/a−$19763.10
Q3 FY25−$3297.00n/a−$26026.35
Q2 FY25−$5384.10n/a−$36531.60
Q1 FY25−$8766.75n/a−$32544.00
Q4 FY24−$8578.50n/a−$69515.25
Q3 FY24−$13802.25n/a−$210561.75
Q2 FY24−$1396.50n/a−$492072.00
Q1 FY24−$45738.00n/a−$1033394.25
Q4 FY23−$149625.00n/a−$2869781.25
Q3 FY23−$295312.50n/a−$5744156.25

Against its peers

Companies in Drug Manufacturers - General nearest Jaguar Health's size, closest first, today.

CompanyEPS, 12 months
JAGXJaguar Health−$6051.75
LABTLakewood-Amedex Biotherapeuticsn/m
NXTSNexentis Technologiesn/m
DCOYDecoy Therapeuticsn/m
VBIOValion Bion/m
SBFMSunshine Biopharman/m
ARTLArtelo Biosciences−$207.09
LNAILunai Bioworksn/m
GNPXGenprexn/m
GOVXGeoVax Labsn/m
ONCOOnconetix−$199.38
Peer median−$203.24

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Jaguar Health

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.